• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人 PSC 衍生的 CD82 ERBB3 NGFR 骨骼肌成肌祖细胞促进高效肌肉再生。

Efficient Muscle Regeneration by Human PSC-Derived CD82 ERBB3 NGFR Skeletal Myogenic Progenitors.

机构信息

Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.

Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455, USA.

出版信息

Cells. 2023 Jan 18;12(3):362. doi: 10.3390/cells12030362.

DOI:10.3390/cells12030362
PMID:36766703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9913306/
Abstract

Differentiation of pluripotent stem cells (PSCs) is a promising approach to obtaining large quantities of skeletal myogenic progenitors for disease modeling and cell-based therapy. However, generating skeletal myogenic cells with high regenerative potential is still challenging. We recently reported that skeletal myogenic progenitors generated from mouse PSC-derived teratomas possess robust regenerative potency. We have also found that teratomas derived from human PSCs contain a skeletal myogenic population. Here, we showed that these human PSC-derived skeletal myogenic progenitors had exceptional engraftability. A combination of cell surface markers, CD82, ERBB3, and NGFR enabled efficient purification of skeletal myogenic progenitors. These cells expressed PAX7 and were able to differentiate into MHC+ multinucleated myotubes. We further discovered that these cells are expandable in vitro. Upon transplantation, the expanded cells formed new dystrophin fibers that reconstituted almost ¾ of the total muscle volume, and repopulated the muscle stem cell pool. Our study, therefore, demonstrates the possibility of producing large quantities of engraftable skeletal myogenic cells from human PSCs.

摘要

多能干细胞(PSCs)的分化是一种有前途的方法,可以获得大量用于疾病建模和基于细胞的治疗的成骨肌祖细胞。然而,产生具有高再生潜力的成骨肌细胞仍然具有挑战性。我们最近报道了从鼠 PSC 衍生的畸胎瘤中产生的成骨肌祖细胞具有强大的再生能力。我们还发现源自人 PSCs 的畸胎瘤中含有成骨肌群体。在这里,我们表明这些人 PSC 衍生的成骨肌祖细胞具有出色的植入能力。细胞表面标志物 CD82、ERBB3 和 NGFR 的组合可有效纯化成骨肌祖细胞。这些细胞表达 PAX7 并能够分化为 MHC+多核肌管。我们进一步发现这些细胞在体外可扩增。移植后,扩增的细胞形成了新的肌营养不良蛋白纤维,几乎重建了 ¾ 的总肌肉体积,并重新填充了肌肉干细胞池。因此,我们的研究表明,从人 PSCs 中产生大量可植入的成骨肌细胞是可能的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/9913306/dad0a972e90e/cells-12-00362-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/9913306/d95ee3ca0b49/cells-12-00362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/9913306/74fd73891466/cells-12-00362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/9913306/3cd844164793/cells-12-00362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/9913306/dad0a972e90e/cells-12-00362-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/9913306/d95ee3ca0b49/cells-12-00362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/9913306/74fd73891466/cells-12-00362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/9913306/3cd844164793/cells-12-00362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/9913306/dad0a972e90e/cells-12-00362-g004.jpg

相似文献

1
Efficient Muscle Regeneration by Human PSC-Derived CD82 ERBB3 NGFR Skeletal Myogenic Progenitors.人 PSC 衍生的 CD82 ERBB3 NGFR 骨骼肌成肌祖细胞促进高效肌肉再生。
Cells. 2023 Jan 18;12(3):362. doi: 10.3390/cells12030362.
2
Producing Engraftable Skeletal Myogenic Progenitors from Pluripotent Stem Cells via Teratoma Formation.通过畸胎瘤形成从多能干细胞产生可移植的骨骼肌祖细胞。
Methods Mol Biol. 2023;2640:175-189. doi: 10.1007/978-1-0716-3036-5_13.
3
In vitro expanded skeletal myogenic progenitors from pluripotent stem cell-derived teratomas have high engraftment capacity.从多能干细胞源性畸胎瘤中体外扩增的骨骼肌成肌祖细胞具有高植入能力。
Stem Cell Reports. 2021 Dec 14;16(12):2900-2912. doi: 10.1016/j.stemcr.2021.10.014. Epub 2021 Nov 18.
4
Defining the Skeletal Myogenic Lineage in Human Pluripotent Stem Cell-Derived Teratomas.定义人多能干细胞源性畸胎瘤中的骨骼肌发生谱系。
Cells. 2022 May 9;11(9):1589. doi: 10.3390/cells11091589.
5
Skeletal Muscle Stem Cells from PSC-Derived Teratomas Have Functional Regenerative Capacity.源自 PSC 源性畸胎瘤的骨骼肌干细胞具有功能性再生能力。
Cell Stem Cell. 2018 Jul 5;23(1):74-85.e6. doi: 10.1016/j.stem.2018.06.010.
6
ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs.ERBB3 和 NGFR 标记了人类发育和 hPSC 中的一种独特的骨骼肌祖细胞。
Nat Cell Biol. 2018 Jan;20(1):46-57. doi: 10.1038/s41556-017-0010-2. Epub 2017 Dec 18.
7
Genomic Safe Harbor Expression of PAX7 for the Generation of Engraftable Myogenic Progenitors.基因组安全港表达 PAX7 生成可植入的成肌祖细胞。
Stem Cell Reports. 2021 Jan 12;16(1):10-19. doi: 10.1016/j.stemcr.2020.11.001. Epub 2020 Dec 3.
8
Myogenic Progenitors from Mouse Pluripotent Stem Cells for Muscle Regeneration.用于肌肉再生的源自小鼠多能干细胞的成肌祖细胞
Methods Mol Biol. 2016;1460:191-208. doi: 10.1007/978-1-4939-3810-0_14.
9
Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice.脂肪来源干细胞中肌源性祖细胞的长期植入及肌营养不良小鼠的肌肉再生
Hum Mol Genet. 2015 Nov 1;24(21):6029-40. doi: 10.1093/hmg/ddv316. Epub 2015 Aug 11.
10
Pluripotent stem cell-derived myogenic progenitors remodel their molecular signature upon in vivo engraftment.多能干细胞衍生的肌源性祖细胞在体内移植后重塑其分子特征。
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4346-4351. doi: 10.1073/pnas.1808303116. Epub 2019 Feb 13.

引用本文的文献

1
Long-Term Engraftment and Satellite Cell Expansion from Human PSC Teratoma-Derived Myogenic Progenitors.源自人多能干细胞畸胎瘤的肌源性祖细胞的长期植入与卫星细胞扩增
Cells. 2025 Jul 25;14(15):1150. doi: 10.3390/cells14151150.
2
PSC differentiation as a platform to identify factors for improving the engraftability of cultured muscle stem cells.将PSC分化作为一个平台,以鉴定改善培养的肌肉干细胞植入能力的因素。
Front Cell Dev Biol. 2024 Feb 15;12:1362671. doi: 10.3389/fcell.2024.1362671. eCollection 2024.

本文引用的文献

1
Defining the Skeletal Myogenic Lineage in Human Pluripotent Stem Cell-Derived Teratomas.定义人多能干细胞源性畸胎瘤中的骨骼肌发生谱系。
Cells. 2022 May 9;11(9):1589. doi: 10.3390/cells11091589.
2
Skeletal muscle differentiation of human iPSCs meets bioengineering strategies: perspectives and challenges.人诱导多能干细胞的骨骼肌分化与生物工程策略:前景与挑战
NPJ Regen Med. 2022 Apr 7;7(1):23. doi: 10.1038/s41536-022-00216-9.
3
In vitro expanded skeletal myogenic progenitors from pluripotent stem cell-derived teratomas have high engraftment capacity.
从多能干细胞源性畸胎瘤中体外扩增的骨骼肌成肌祖细胞具有高植入能力。
Stem Cell Reports. 2021 Dec 14;16(12):2900-2912. doi: 10.1016/j.stemcr.2021.10.014. Epub 2021 Nov 18.
4
Directed Differentiation of Human Pluripotent Stem Cells toward Skeletal Myogenic Progenitors and Their Purification Using Surface Markers.人多能干细胞向成肌前体细胞的定向分化及其表面标志物的纯化。
Cells. 2021 Oct 14;10(10):2746. doi: 10.3390/cells10102746.
5
In vivo functions of p75: challenges and opportunities for an emerging therapeutic target.p75 在体内的功能:新兴治疗靶点的挑战与机遇。
Trends Pharmacol Sci. 2021 Sep;42(9):772-788. doi: 10.1016/j.tips.2021.06.006. Epub 2021 Jul 29.
6
Defining the Teratoma as a Model for Multi-lineage Human Development.将畸胎瘤定义为多谱系人类发育的模型。
Cell. 2020 Nov 25;183(5):1402-1419.e18. doi: 10.1016/j.cell.2020.10.018. Epub 2020 Nov 4.
7
A Myogenic Double-Reporter Human Pluripotent Stem Cell Line Allows Prospective Isolation of Skeletal Muscle Progenitors.一种肌源性双报告人人类多能干细胞系可用于预期分离骨骼肌祖细胞。
Cell Rep. 2018 Nov 13;25(7):1966-1981.e4. doi: 10.1016/j.celrep.2018.10.067.
8
Skeletal Muscle Stem Cells from PSC-Derived Teratomas Have Functional Regenerative Capacity.源自 PSC 源性畸胎瘤的骨骼肌干细胞具有功能性再生能力。
Cell Stem Cell. 2018 Jul 5;23(1):74-85.e6. doi: 10.1016/j.stem.2018.06.010.
9
ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs.ERBB3 和 NGFR 标记了人类发育和 hPSC 中的一种独特的骨骼肌祖细胞。
Nat Cell Biol. 2018 Jan;20(1):46-57. doi: 10.1038/s41556-017-0010-2. Epub 2017 Dec 18.
10
PAX7 Targets, CD54, Integrin α9β1, and SDC2, Allow Isolation of Human ESC/iPSC-Derived Myogenic Progenitors.PAX7靶点、CD54、整合素α9β1和SDC2可用于分离人胚胎干细胞/诱导多能干细胞来源的成肌祖细胞。
Cell Rep. 2017 Jun 27;19(13):2867-2877. doi: 10.1016/j.celrep.2017.06.005.